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contacts of active tuberculosis patients
M. Ali1,∗, G. Velásquez2, M. Murray3
1 Icahn School of Medicine at Mount Sinai, New York,
NY, USA
2 Brigham and Women’s Hospital, Boston, USA
3 Harvard School of Public Health, Boston, USA
Background: Recognized risk factors do not explain the full
variability of transmission for tuberculosis. Analyses of other
host and environmental risk factors are required, including the
bacille Calmette–Guérin (BCG) vaccine, whose effect for tuberculo-
sis transmission is currently understood to be limited.
Methods & Materials: Between September 2009 and August
2012, we identiﬁed and enrolled active tuberculosis patients in
Lima, Peru.Withinonemonthof enrollmentof these indexpatients,
study nurses visited patients’ households to enroll their household
contacts. We assessed the number of BCG scars on the house-
hold contact, as well as other risk factors for infection speciﬁc to
the household contact, index tuberculosis patient, or the house-
hold. Household contacts underwent tuberculin skin testing (TST)
to determine tuberculosis infection status at enrollment and at
follow-up visits at six and twelve months, as appropriate. We used
generalizedestimatingequations tomodel the associationbetween
number of BCG scars on the household contact and tuberculosis
transmission as measured by (a) TST positivity at baseline and (b)
TST conversion during follow-up.
Results: Among 10,314 household contacts of 2,700 index
patients, 4,204 (40.8%) contacts were TST-positive at enrollment.
After adjusting for other risk factors, we found that household con-
tacts with three or more BCG scars had 19% increased risk of being
TST positive, compared to household contacts without any BCG
scars (adjusted RR, 1.19; 95% CI, 1.07–1.31; Ptrend<0.001). During
the 12-month follow-up period, household contacts with three or
more BCG scars had 72% increased risk of becoming TST positive
every six months, compared to household contacts without any
BCG scars (adjusted RR, 1.72; 95% CI, 1.30–2.3; Ptrend<0.001).
Conclusion: This is one of the largest cohort studies to date
focusing on tuberculosis transmission. Our analyses suggest house-
hold contacts with more BCG scars are more likely to become
TST-positive in the context of exposure to active tuberculosis
patients. However, our analyses to date cannot deﬁnitely distin-
guish whether this reﬂects increased susceptibility to tuberculosis
infection or another form of BCG boosting, which remains the sub-
ject of future research.
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Predictors of adherence to isoniazid preventive
therapy in HIV patients in Ethiopia: A
prospective cohort study
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Background: Isoniazid preventive therapy (IPT) is efﬁcacious
in prevention of tuberculosis (TB) in Human Immunodeﬁciency
Virus (HIV) infected persons. Yet, patients’ adherence to this strat-
egy is suboptimal, its determinants are largely unknown and data
are lacking from prospective cohorts. This study aimed to identify
predictors of HIV patients’ adherence to IPT.
Methods & Materials: This prospective cohort study was con-
ducted in the HIV/AIDS chronic care unit of Dilla University
Hospital, Ethiopia, from May 2014 to February 2015. Adherence
wasdeﬁned as completion of the 6-month course of treatmentwith
90% of pills taken (measured by diary and pill count). Data was
collected on potential predictors including patients’ demographic
and clinical characteristics. Univariable and multivariable logistic
regression models were ﬁtted to identify independent predictors
of adherence to IPT. The discriminative ability of logistic regres-
sionmodelswas assessed by the area under the Receiver Operating
Characteristic (ROC) curve and corrected for over-optimism using
bootstrapping techniques.
Results: 162 HIV patients were included and 104 (64.2%) were
adherent to IPT. In the ﬁnal multivariable model, concomitant
use of antiretroviral therapy (ART) and/or prophylactic cotrimox-
azole therapy was associated with adherence to IPT [OR= 2.66;
95% CI (1.15, 6.17)]. Experiencing high level of HIV stigma and
episodes of opportunistic infections tended to be associated with
non-adherence to IPT [OR=0.51; 95% CI (0.25, 1.04)] and [OR=0.14;
95% CI (0.02, 1.15)]. The optimism-corrected area under the ROC
curveof theﬁnalmodelwas67% [C index=0.67; 95%CI (0.57, 0.74)].
The calibration plot showed reasonable calibration.
Table 2. Multivariable analysis of predictors of IPT adherence in
HIV patients of Dilla University hospital
Predictors Multivariable OR 95% CI
Concomitant ART or co-trimoxazole 2,66 (1.15, 6.17)
Opportunistic infections 0.51 (0.25, 1.04)
HIV Stigma & Discrimination Low 1
Moderate 0.15 (0.02, 1.37)
High 0,14 (0.02, 1.15)
Conclusion: HIV patients receiving ART or cotrimoxazole ther-
apyweremore likely to adhere to IPT.We recommend studieswith
larger sample size to assess the effect of other potential predictors
and incidence of adverse drug reaction after IPT-ART concomitant
therapies. Population level and health care provider- associated
determinants of IPT uptake should be investigated.
http://dx.doi.org/10.1016/j.ijid.2016.02.827
